Speaker illustration

Miss Ana Ferreira

Barts Health NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

Dual cardioprotection improves right and left ventricular systolic function in patients receiving cardiotoxic chemotherapy

Event: Heart Failure 2018

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb